# Oaktree Specialty Lending Corp: financial statements, quarterly

OCSL · Nasdaq · CIK 1414932 · [Other](/sectors/other.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/ocsl.md) · [Financials](/companies/ocsl/financials.md) · [Filings](/companies/ocsl/filings.md) · [Insiders](/companies/ocsl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ocsl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [32.3 d](/filings/0001414932-25-000022.md) | [32.2](/filings/0001414932-25-000004.md) | [31.9](/filings/0001414932-25-000010.md) | [32.5](/filings/0001414932-25-000016.md) | [32.1 d](/filings/0001414932-25-000022.md) | [30.6](/filings/0001414932-26-000005.md) | [28.2](/filings/0001414932-26-000012.md) | [31.1](/filings/0001414932-26-000017.md) | [26.0 d](/filings/0001414932-25-000022.md) | [26.7](/filings/0001414932-26-000005.md) | [25.6](/filings/0001414932-26-000012.md) | [24.1](/filings/0001414932-26-000017.md) |
| Income tax | $m | not reported | not reported | not reported | [1.0](/filings/0001414932-24-000012.md) | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001414932-25-000022.md) | not reported | not reported | [0.3](/filings/0001414932-26-000017.md) |
| Net income | $m | [46.0 d](/filings/0001414932-25-000022.md) | [10.5](/filings/0001414932-25-000004.md) | [9.3](/filings/0001414932-25-000010.md) | [1.1](/filings/0001414932-25-000016.md) | [36.9 d](/filings/0001414932-25-000022.md) | [7.2](/filings/0001414932-26-000005.md) | [(36.2)](/filings/0001414932-26-000012.md) | [38.4](/filings/0001414932-26-000017.md) | [24.6 d](/filings/0001414932-25-000022.md) | [5.6](/filings/0001414932-26-000005.md) | [(18.9)](/filings/0001414932-26-000012.md) | [30.9](/filings/0001414932-26-000017.md) |
| Diluted EPS | $ per share | not reported | [0.14](/filings/0001414932-25-000004.md) | [0.12](/filings/0001414932-25-000010.md) | [0.01](/filings/0001414932-25-000016.md) | not reported | [0.09](/filings/0001414932-26-000005.md) | [(0.42)](/filings/0001414932-26-000012.md) | [0.44](/filings/0001414932-26-000017.md) | not reported | [0.06](/filings/0001414932-26-000005.md) | [(0.21)](/filings/0001414932-26-000012.md) | [0.35](/filings/0001414932-26-000017.md) |
| Basic EPS | $ per share | not reported | [0.14](/filings/0001414932-25-000004.md) | [0.12](/filings/0001414932-25-000010.md) | [0.01](/filings/0001414932-25-000016.md) | not reported | [0.09](/filings/0001414932-26-000005.md) | [(0.42)](/filings/0001414932-26-000012.md) | [0.44](/filings/0001414932-26-000017.md) | not reported | [0.06](/filings/0001414932-26-000005.md) | [(0.21)](/filings/0001414932-26-000012.md) | [0.35](/filings/0001414932-26-000017.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [136](/filings/0001414932-25-000022.md) | [112](/filings/0001414932-24-000004.md) | [125](/filings/0001414932-24-000008.md) | [96.3](/filings/0001414932-24-000012.md) | [64.0](/filings/0001414932-25-000022.md) | [113](/filings/0001414932-25-000004.md) | [97.8](/filings/0001414932-25-000010.md) | [79.8](/filings/0001414932-25-000016.md) | [79.6](/filings/0001414932-26-000017.md) | [80.8](/filings/0001414932-26-000005.md) | [51.3](/filings/0001414932-26-000012.md) | [39.9](/filings/0001414932-26-000017.md) |
| Total assets | $m | [3,218](/filings/0001414932-24-000016.md) | [3,266](/filings/0001414932-24-000004.md) | [3,298](/filings/0001414932-24-000008.md) | [3,322](/filings/0001414932-24-000012.md) | [3,198](/filings/0001414932-25-000022.md) | [3,084](/filings/0001414932-25-000004.md) | [3,079](/filings/0001414932-25-000010.md) | [2,964](/filings/0001414932-25-000016.md) | [3,003](/filings/0001414932-26-000017.md) | [3,098](/filings/0001414932-26-000005.md) | [2,894](/filings/0001414932-26-000012.md) | [2,858](/filings/0001414932-26-000017.md) |
| Total liabilities | $m | [1,702](/filings/0001414932-24-000016.md) | [1,755](/filings/0001414932-24-000004.md) | [1,774](/filings/0001414932-24-000008.md) | [1,826](/filings/0001414932-24-000012.md) | [1,711](/filings/0001414932-25-000022.md) | [1,634](/filings/0001414932-25-000004.md) | [1,604](/filings/0001414932-25-000010.md) | [1,488](/filings/0001414932-25-000016.md) | [1,537](/filings/0001414932-26-000017.md) | [1,662](/filings/0001414932-26-000005.md) | [1,512](/filings/0001414932-26-000012.md) | [1,475](/filings/0001414932-26-000017.md) |
| Long-term debt | $m | [1,601](/filings/0001414932-24-000016.md) | [1,623](/filings/0001414932-24-000004.md) | [1,636](/filings/0001414932-24-000008.md) | [1,697](/filings/0001414932-24-000012.md) | [1,639](/filings/0001414932-25-000022.md) | [1,578](/filings/0001414932-25-000004.md) | [1,448](/filings/0001414932-25-000010.md) | [1,448](/filings/0001414932-25-000016.md) | [1,487](/filings/0001414932-26-000017.md) | [1,610](/filings/0001414932-26-000005.md) | [1,482](/filings/0001414932-26-000012.md) | [1,439](/filings/0001414932-26-000017.md) |
| Shareholders' equity | $m | [1,516](/filings/0001414932-25-000022.md) | [1,512](/filings/0001414932-25-000016.md) | [1,524](/filings/0001414932-25-000016.md) | [1,496](/filings/0001414932-25-000016.md) | [1,488](/filings/0001414932-26-000017.md) | [1,450](/filings/0001414932-26-000017.md) | [1,475](/filings/0001414932-26-000017.md) | [1,476](/filings/0001414932-26-000017.md) | [1,466](/filings/0001414932-26-000017.md) | [1,436](/filings/0001414932-26-000017.md) | [1,382](/filings/0001414932-26-000017.md) | [1,383](/filings/0001414932-26-000017.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [244 d](/filings/0001414932-25-000022.md) | [1.1](/filings/0001414932-25-000004.md) | [(17.6) d](/filings/0001414932-25-000010.md) | [(59.9) d](/filings/0001414932-25-000016.md) | [95.5 d](/filings/0001414932-25-000022.md) | [144](/filings/0001414932-26-000005.md) | [62.0 d](/filings/0001414932-26-000012.md) | [21.1 d](/filings/0001414932-26-000017.md) | [1.3 d](/filings/0001414932-25-000022.md) | [(83.5)](/filings/0001414932-26-000005.md) | [131 d](/filings/0001414932-26-000012.md) | [57.6 d](/filings/0001414932-26-000017.md) |
| Dividends paid | $m | [40.9 d](/filings/0001414932-25-000022.md) | [47.0](/filings/0001414932-25-000004.md) | [42.9 d](/filings/0001414932-25-000010.md) | [43.3 d](/filings/0001414932-25-000016.md) | [43.7 d](/filings/0001414932-25-000022.md) | [43.8](/filings/0001414932-26-000005.md) | [37.1 d](/filings/0001414932-26-000012.md) | [33.2 d](/filings/0001414932-26-000017.md) | [34.1 d](/filings/0001414932-25-000022.md) | [34.1](/filings/0001414932-26-000005.md) | [34.1 d](/filings/0001414932-26-000012.md) | [28.9 d](/filings/0001414932-26-000017.md) |
| Share repurchases | $m | [0.0 d](/filings/0001414932-25-000022.md) | [0.0](/filings/0001414932-25-000004.md) | [0.0 d](/filings/0001414932-25-000010.md) | [0.0 d](/filings/0001414932-25-000016.md) | [1.6 d](/filings/0001414932-25-000022.md) | [1.5](/filings/0001414932-26-000005.md) | [4.3 d](/filings/0001414932-26-000012.md) | [3.8 d](/filings/0001414932-26-000017.md) | [1.2 d](/filings/0001414932-25-000022.md) | [1.1](/filings/0001414932-26-000005.md) | [1.1 d](/filings/0001414932-26-000012.md) | [1.1 d](/filings/0001414932-26-000017.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q4 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [61.1](/filings/0001414932-24-000004.md) | [73.2](/filings/0001414932-24-000008.md) | [77.1](/filings/0001414932-24-000012.md) | [77.8](/filings/0001414932-25-000004.md) | [79.8](/filings/0001414932-25-000010.md) | [81.8](/filings/0001414932-25-000016.md) | [82.2](/filings/0001414932-26-000005.md) | [85.9](/filings/0001414932-26-000012.md) | [88.1](/filings/0001414932-26-000017.md) | [88.1](/filings/0001414932-26-000005.md) | [88.1](/filings/0001414932-26-000012.md) | [88.1](/filings/0001414932-26-000017.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 88,085,523 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001414932-26-000017.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.